FDA Updates Prevention, Diagnosis, and Treatment Policies in Response to COVID-19
To limit the spread of COVID-19 throughout the United States, the Food and Drug Administration (FDA) has promulgated policies to focus on the prevention, diagnosis, and treatment of the COVID-19 virus. Further, as states implement COVID-19 control measures, some day-to-day enforcement regulations…
UPDATE: Hospital Staffing Disruption COVID-19
With the continued spread of COVID-19 and the increased burden on our healthcare system, the Centers for Disease Control (CDC) has again issued new guidance. After the CDC issued its return-to-work guidance for healthcare personnel (HCP) with potential exposure to a COVID-19 patient, it issued…
CMS Makes Toolbox Available to Streamline Relief for State Medicaid and CHIP Programs During COVID-19 Outbreak
Centers for Medicare & Medicaid Services (CMS) announced new tools and resources on March 22, 2020, to support state Medicaid and Children’s Health Insurance Programs (CHIP) during the COVID-19 outbreak. These tools relate to (1) Section 1115 waivers; (2) Section 1135 waivers; (3) Section 1915(c)…
NAIC Special Session on COVID-19
Today, the National Association of Insurance Commissioners (NAIC) held a Special Session on COVID-19. A presentation on virus progression and pathology was made by Dr. Jay Butler, Deputy Director for Infectious Disease a Centers for Disease Control and Prevention (CDC). After Dr. Butler’s…
Telemedicine to Combat COVID-19
Regulators at both the federal and state level are using expansion of telemedicine to help communities fight back against the spread of COVID-19. On Friday, March 13, President Trump declared a National Emergency related to COVID-19 and outlined a number of areas where he has conferred authority on…